Invivoscribe Controls Portfolio Catalogue 2024
Discover the Invivoscribe control portfolio
Invivoscribe offers an extensive range of General Purpose Reagents (GPRs) and Research Use Only (RUO) controls.
11Oct
News
28May
Invivoscribe NPM1 MRD Assay
Just launched! NPM1 MRD Assay* by Invivoscribe.
21Mar
New Invivoscribe FLT3 ITD MRD Assay
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
Just launched! Invivoscribe’s FLT3 ITD MRD Assay for Acute Myeloid Leukemia (AML)
05Jul
Advantages of NGS for MRD testing
Products are for professional/laboratory use only
Explore Recent Scientific Contributions Using Invivoscribe’s Products
Key opinion leaders across the world have recently published papers that discuss the advantages of using highly sensitive next-generation sequencing (NGS) for Minimal Residual Disease (MRD) testing.
03Feb
Invivoscribe’s EHA Symposiums Now Available on Demand
Products are for professional/laboratory use only.
The Invivoscribe symposiums presented during the 25th European Hematology Association Virtual Congress are now available to watch on demand.
02Feb
Invivoscribe MRD controls NOW AVAILABLE
Products are for professional/laboratory use only.
Abacus dx is pleased to announce the launch of the new LymphoTrack B-cell Low Positive Controls and LymphoQuant B-cell Internal Controls as part of Invivoscribe’s MRD B-Cell Bundled Solution.